CONMED Corporation to Participate in the 40th Annual JP Morgan Virtual Healthcare Conference

Rhea-AI Summary

CONMED Corporation (NYSE: CNMD) will present at the 40th Annual J.P. Morgan Virtual Healthcare Conference on January 10, 2022, at 9:00 a.m. ET. The presentation will feature Curt R. Hartman, Chair of the Board, President & CEO, and Todd W. Garner, Executive Vice President and CFO. Investors can access a live webcast through the Company’s website, with a replay available afterward. CONMED is a medical technology company providing surgical devices for minimally invasive procedures across various specialties.

LARGO, Fla.--(BUSINESS WIRE)-- CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President & Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present at the 40th Annual J.P. Morgan Virtual Healthcare Conference at 9:00 a.m. ET on Monday, January 10, 2022.

A live webcast of the presentation will be accessible through the “Investors” section of the Company’s website at www.conmed.com and will be available for replay following the event.

About CONMED Corporation

CONMED is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company’s products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. For more information, visit www.conmed.com.

Forward-Looking Statements

This press release and the associated presentation may contain forward-looking statements based on certain assumptions and contingencies that involve risks and uncertainties, which could cause actual results, performance, or trends to differ materially from those expressed in the forward-looking statements herein or in previous disclosures. For example, in addition to general industry and economic conditions, factors that could cause actual results to differ materially from those in the forward-looking statements may include, but are not limited to, the risks posed to the Company’s business, financial condition, and results of operations by the COVID-19 global pandemic and the various government and other responses to the pandemic, including deferral of surgeries, reductions in hospital and ambulatory surgery center operating volumes, disruption to potential supply chain reliability, as well as the risk factors discussed in the Company's Annual Report on Form 10-K for the full year ended December 31, 2020 and listed under the heading Forward-Looking Statements in the Company’s most recently filed Form 10-Q. Any and all forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and relate to the Company’s performance on a going-forward basis. The Company believes that all forward-looking statements made by it have a reasonable basis, but there can be no assurance that management’s expectations, beliefs or projections as expressed in the forward-looking statements will actually occur or prove to be correct.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220103005027/en/

CONMED Corporation

Todd W. Garner

Chief Financial Officer

727-214-2975

ToddGarner@conmed.com

Source: CONMED Corporation

FAQ

When will CONMED Corporation present at the J.P. Morgan Virtual Healthcare Conference?

CONMED Corporation will present on January 10, 2022, at 9:00 a.m. ET.

Who will be presenting for CONMED at the 40th Annual J.P. Morgan Virtual Healthcare Conference?

Curt R. Hartman and Todd W. Garner will be presenting for CONMED.

How can I access the CONMED presentation at the J.P. Morgan Conference?

The presentation will be available via a live webcast on CONMED's website.

What type of products does CONMED Corporation provide?

CONMED Corporation provides surgical devices and equipment for minimally invasive procedures.

What specialties do CONMED's products cater to?

CONMED's products are used in orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology.